receptor
receptor
批准号:
23590532
负责人:
OKADA Masaji
金额:
$3.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cytotoxic T cells against M. tuberculosis are one of most important immune cells for the protection of tuberculosis infection in human.(1)It was demonstrated first that HSP65 DNA+IL-12 DNA vaccine (HSP65 vaccine) and 15K Granulysin vaccine exerted the activity of cytotoxic T cell differentiation factor in the present study. (2)Therefore, the presence of the receptor for granulysin was strongly suggested. We are now isolating the granulysin receptor. (3)We found granulysin-granulysin positive feedback loop. Granulysin was produced from CTL, and granulysin act on the differentiation of CTL. (4)HSP65 vaccine and Granulysin vaccine exerted synergistic therapeutic efficacy against TB infection in mice, and showed the synergistic differentiation of CTL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A novel therapeutic and prophylactic vaccines against tuberculosis by the activation of CTL in monkey models and murine models
通过在猴模型和小鼠模型中激活 CTL 来治疗和预防结核病的新型疫苗
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Hongo S, Muraki Y, Shimotai Y, Okada M]
通讯作者:
Okada M
新しい結核治療ワクチンの開発(Hsp65+IL-12 DNAワクチン)と他の薬剤・ワクチンとの相乗効果及びキラーT細胞分化
新型结核病治疗疫苗(Hsp65+IL-12 DNA疫苗)的开发、与其他药物/疫苗的协同作用、杀伤性T细胞分化
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[喜多洋子, 橋元里実, 林清二, 岡田全司]
通讯作者:
岡田全司
The study of novel DNA vaccines against tuberculosis : Induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis
新型结核病 DNA 疫苗的研究:在小鼠和猴结核病模型中诱导病原体特异性 CTL
DOI:
--
发表时间:
2013
期刊:
Human Vaccines and Immunotherapeutics
影响因子:
4.8
作者:
[Okada M, Kita Y]
通讯作者:
Kita Y
Development of therapeutic and prophylactic vaccine against tuberculosis using monkey and granulysin transgenic mice models
使用猴和颗粒溶素转基因小鼠模型开发治疗性和预防性结核病疫苗
DOI:
--
发表时间:
2011
期刊:
Human Vaccines
影响因子:
--
作者:
[Kita Y, Okada M, et al.]
通讯作者:
et al.
はじめに(序論)
介绍
DOI:
--
发表时间:
2013
期刊:
最新医学
影响因子:
--
作者:
[Jinushi M, Yagita H, Yoshiyama H, Tahara H, 岡田全司]
通讯作者:
岡田全司
共 52 条
The study of the mechanism of therapeutic efficacy of novel vaccines on Tuberculosis-infection and the induction of cytotoxic T cells by the vaccines
-
批准号:18390138
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.16万
-
财政年份:2006
-
负责人:OKADA Masaji
-
依托单位:
Establishment of Novel (DNA-recombinant BCG-, and fusion protein-)vaccination against Tuberculosis and analysis of novel differentiation mechanism of cytotoxic T cell
-
批准号:14570294
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2002
-
负责人:OKADA Masaji
-
依托单位:
国内基金
海外基金
分泌颗粒溶素granulysin的T细胞在抗结核杆菌感染免疫应答中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:沈洪波
-
依托单位:
T淋巴细胞颗粒溶素(granulysin)表达的基因调控机制的研究
-
批准号:30972670
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:郑春福
-
依托单位: